Cite
MLA Citation
Lukas D. Wartman et al.. “A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia.” Leukemia & lymphoma, vol. 57, no. 3, n.d., pp. 728–730. http://access.bl.uk/ark:/81055/vdc_100034281744.0x000025